Aging-focused biotech companies share how they're advancing therapies to slow disease, extend lifespan, and transform medicine.
Researchers are uncovering how disrupted glutamatergic synapses drive diverse forms of intellectual disability, revealing new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback